Adrenomedullin vs Apelin-13 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Adrenomedullin (ADM) is a 52-amino acid vasoactive peptide first isolated from human pheochromocytoma tissue in 1993. It is now recognized as a pleiotropic hormone produced widely throughout the body, with highest expression in the adrenal medulla, heart, lung, kidney, and vascul...
Calculate Adrenomedullin dose →Apelin-13 is the most biologically active isoform of the apelin peptide family, endogenous ligands for the APJ receptor (also called APLNR). Apelin peptides are produced throughout the body, with the heart, lung, brain, and adipose tissue expressing particularly high levels....
Calculate Apelin-13 dose →| Parameter | Adrenomedullin | Apelin-13 |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Clinical |
| Half-Life | 22 min (plasma) | < 5 min (plasma) |
| Typical Dose | 2-10 ng/kg/min (IV infusion) | 50-300 nmol/kg |
| Frequency | Acute infusion or short course | Variable |
| Route | Intravenous, Subcutaneous | Intravenous (research), Subcutaneous |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.